CN104116071B - Lac regis apis Semen Litchi Grifola frondosa microcapsule and preparation method thereof - Google Patents
Lac regis apis Semen Litchi Grifola frondosa microcapsule and preparation method thereof Download PDFInfo
- Publication number
- CN104116071B CN104116071B CN201410232902.8A CN201410232902A CN104116071B CN 104116071 B CN104116071 B CN 104116071B CN 201410232902 A CN201410232902 A CN 201410232902A CN 104116071 B CN104116071 B CN 104116071B
- Authority
- CN
- China
- Prior art keywords
- parts
- lac regis
- regis apis
- grifola frondosa
- microcapsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 240000001080 Grifola frondosa Species 0.000 title claims abstract description 47
- 235000007710 Grifola frondosa Nutrition 0.000 title claims abstract description 47
- 239000003094 microcapsule Substances 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000000284 extract Substances 0.000 claims abstract description 21
- 244000183278 Nephelium litchi Species 0.000 claims abstract description 20
- 239000003292 glue Substances 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 18
- 239000012530 fluid Substances 0.000 claims abstract description 16
- 229930006000 Sucrose Natural products 0.000 claims abstract description 15
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 15
- 239000005720 sucrose Substances 0.000 claims abstract description 15
- 108010010803 Gelatin Proteins 0.000 claims abstract description 14
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 14
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 14
- 235000010489 acacia gum Nutrition 0.000 claims abstract description 14
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims abstract description 14
- 239000008273 gelatin Substances 0.000 claims abstract description 14
- 229920000159 gelatin Polymers 0.000 claims abstract description 14
- 235000019322 gelatine Nutrition 0.000 claims abstract description 14
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 14
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 14
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 5
- 239000002245 particle Substances 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 19
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 12
- 239000008103 glucose Substances 0.000 abstract description 12
- 235000012000 cholesterol Nutrition 0.000 abstract description 9
- 150000004676 glycans Chemical class 0.000 abstract description 4
- 229920001282 polysaccharide Polymers 0.000 abstract description 4
- 239000005017 polysaccharide Substances 0.000 abstract description 4
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 3
- 230000009467 reduction Effects 0.000 abstract description 3
- HBOQXIRUPVQLKX-UHFFFAOYSA-N 2,3-di(octadeca-9,12-dienoyloxy)propyl octadeca-9,12-dienoate Chemical compound CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC HBOQXIRUPVQLKX-UHFFFAOYSA-N 0.000 abstract description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 2
- 241000256836 Apis Species 0.000 description 61
- 239000011162 core material Substances 0.000 description 24
- 238000011282 treatment Methods 0.000 description 7
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000011669 selenium Substances 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 150000001336 alkenes Chemical class 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 229940055726 pantothenic acid Drugs 0.000 description 3
- 235000019161 pantothenic acid Nutrition 0.000 description 3
- 239000011713 pantothenic acid Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 2
- QHBZHVUGQROELI-SOFGYWHQSA-N (E)-10-hydroxydec-2-enoic acid Chemical compound OCCCCCCC\C=C\C(O)=O QHBZHVUGQROELI-SOFGYWHQSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000256844 Apis mellifera Species 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- QHBZHVUGQROELI-UHFFFAOYSA-N Royal Jelly acid Natural products OCCCCCCCC=CC(O)=O QHBZHVUGQROELI-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- FKWGCEDRLNNZOZ-GFCCVEGCSA-N Xanthorrhizol Chemical compound CC(C)=CCC[C@@H](C)C1=CC=C(C)C(O)=C1 FKWGCEDRLNNZOZ-GFCCVEGCSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-MBNYWOFBSA-N 7,8-dimethyl-10-[(2R,3R,4S)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-MBNYWOFBSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- MPIZVHPMGFWKMJ-UHFFFAOYSA-N CPD-9757 Chemical compound OC(=O)C(N)C1CC1=C MPIZVHPMGFWKMJ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 241001537207 Flammulina Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 235000015742 Nephelium litchi Nutrition 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 229930016183 alpha-curcumene Natural products 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 208000013507 chronic prostatitis Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 1
- 208000018934 joint symptom Diseases 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000002885 octadecanoids Chemical class 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- -1 steroid compounds Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- ZTUXEFFFLOVXQE-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O ZTUXEFFFLOVXQE-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- FKWGCEDRLNNZOZ-UHFFFAOYSA-N xanthorrhizol Natural products CC(C)=CCCC(C)C1=CC=C(C)C(O)=C1 FKWGCEDRLNNZOZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Jellies, Jams, And Syrups (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a kind of Lac regis apis Semen Litchi Grifola frondosa microcapsule and preparation method thereof, this microcapsule is made up of outer layer glue wall and internal layer core, described internal layer core is calculated by weight as the Lac regis apis of 40～80 parts, the Grifola frondosa extracting solution of 20～40 parts and the litchi nucleus extract fluid of 5～20 parts, and described outer layer glue wall is calculated by weight as the arabic gum of 100～125 parts, the maltodextrin of 100～125 parts, the gelatin of 10～30 parts and the sucrose of 20～35 parts.The method is to be mixed homogeneously with outer wall material by internal layer core, after emulsifying, by pelletize, wall material is solidified, and obtaining particle diameter is 1～20 μm Lac regis apis Semen Litchi Grifola frondosa microcapsules.The polysaccharide that the microcapsule of the present invention contains has the positive role of minimizing blood glucose (sugared).The unsaturated fatty acid being included in Effects of Extracts of Grifola frondosa on Active such as linolein, has the effect of reduction blood glucose, cholesterol and arteriosclerosis equally.
Description
Technical field
The present invention relates to Lac regis apis microcapsule, in particular to a kind of Lac regis apis Semen Litchi Grifola frondosa microcapsule and preparation method thereof.
Background technology
Lac regis apis is the bee product that a class component is considerably complicated, and it is along with bee species, age, season, the difference of pollen plant, and its chemical composition is the most different.In general, its composition is: moisture content 64.5～69.5%, crude protein 11～14.5%, carbohydrate 13～15%, lipid 6.0%, mineral 0.4～2%.
Protein accounts for the 50% of Lac regis apis dry, and wherein having 2/3 is albumin, and 1/3 is globulin, and the protein in Lac regis apis has more than 12 kinds, in addition with many small peptides.
Aminoacid accounts for the 1.8% of Lac regis apis dry weight, 8 kinds of essential amino acids required in human body, has existence in Lac regis apis, and wherein proline content a maximum of about of accounts for 63%, has found 20 kinds of aminoacid at present in Lac regis apis.
Lac regis apis contains nucleic acid, wherein the aobvious weight of the micro-gram gram of DNA (deoxyribonucleic acid) (DNA) 201～223, the aobvious weight of ribonucleic acid 3.9～4.9 milligrams per gram.
Containing 20～the saccharide of 30% (dry weight) in Lac regis apis, the most substantially containing fructose 52%. glucose 45%, sucrose 1%, maltose 1%, gentiobiose 1%.
It is the abundantest that Lac regis apis contains more vitamin, especially vitamin B group.Mainly have: thiamine (B1), riboflavin (B2), pyridoxol (B6), vitamin B12, nicotinic acid, pantothenic acid, folic acid, biotin, inositol, vitamin C, vitamin D etc., wherein pantothenic acid content is the highest.
Lac regis apis contains the fatty acid of more than 26 kinds, the most certified have 12 kinds, they are 10-HAD (10-HDA), capric acid, n-nonanoic acid, hendecanoic acid, dodecylic acid, tetradecanoic acid (myristic acid), myristoleic acid, hexadecanoic acid (Palmic acid), octadecanoid acid, palmitoleic acid, arachidic acid and linoleic acid etc., wherein 10-HAD, content is more than 1.4%, owing to nature only having containing this material in Lac regis apis, so also it being referred to as Royal Jelly acid.
Lac regis apis contains 9 kinds of steroid compounds, the most identified go out three kinds, they are stigmasterol, cholesterol and sitoesterol.Additionally possibly together with mineral, ferrum, copper, magnesium, zinc, potassium, sodium etc..
Effect of Lac regis apis:
1) Lac regis apis contains acetylcholine, and vegetative nerve can be made to recover normal, notable to treatment cardiovascular diseases's effect；
2) Lac regis apis is rich in vitamin B and high quality protein, particularly containing the royal jelly acid that sterilizing power is strong, thus is good medicine for cancer；
3) Lac regis apis has promotion hemopoietic function effect, and developmental children can increase hemoglobin, promotes growth, improves premunition；
4) Lac regis apis is contained within pantothenic acid, can improve rheumatism and joint symptoms；
5) Lac regis apis contains para-insulin, and diabetes are had better effects；
6) Lac regis apis can strengthen adrenal cortex function, regulates human hormone, brain cell between activation, is conducive to treatment climacteric disfunction and chronic prostatitis syndrome；
7) Lac regis apis can strengthen the basis muscle power of people, makes human senility tissue activate, and after clothes, appetite is good, and long spirit, complexion is good；
8) peptide contained by Lac regis apis and protein-based healthy ingredient, can promote intelligent development, thus take and can improve memory；
9) Lac regis apis contains proteohormone, with blood circulation whole body after clothes, contributes to skin histology functional recovery vigor, treatment is scalded effect obvious；
10) Lac regis apis contains plurality of inorganic salt, can promote that glycogen discharges, and promotes metabolism, thus can improve looks, and eliminates speckle.
But, Lac regis apis, to thermoae instability, is placed one day at normal temperatures, and freshness is decreased obviously, about 130 degree inefficacies.But the most stable, can preserve when-2 spend 1 year, the several years can be preserved when-18 spend constant.Lac regis apis exposes in atmosphere, can play oxidation, hydrolysis, and light has catalytic action to Lac regis apis, and its aldehyde radical, ketone group are risen reduction.
nullGrifola frondosa is nutritious，Its nutrient content is done in Grifola frondosa and (is wherein contained amino acid needed by human body 18 kinds 18.68 grams through Chinese Academy Of Preventive Medicine Research Institute Of Nutrition And Food Hygiene and the Ministry of Agriculture's each hectogram of Product Quality Verification Centers detection containing 25.2 grams of protein，Wherein must base acid account for 45.5%) fat 3.2 grams、Dietary fiber 33.7 grams、Carbohydrate 21.4 grams，Ash 5.1 grams、Mineral rich in multiple beneficial，Potassium、Phosphorus、Ferrum、Zinc、Calcium、Copper、Selenium、Chromium etc.，Vitamin content enriches，VE109.7 milligram、VB11.47 milligram、VB20.72 milligram、VC17.0 milligram，Carotene 4.5 milligrams. various nutrients occupies first of various edible fungi，Wherein VB1 and VE content is the highest 10～20 times，VC content is 3～5 times that it is similar，Protein and aminoacid are 2 times of Lentinus Edodes，Can promote that children's torso is grown up healthy and sound and intelligent development，In relevant arginine and lysine content relatively Flammulina velutiper (Fr.) Sing, the content of lysine (1.024%) and arginine (1.231%) is high；The Aspartic Acid relevant with delicate flavour and content of glutamic acid are higher, are therefore described as " edible fungi prince " and " North China Radix Ginseng ".
Grifola frondosa has high medical health care function.According to reported in literature, it has suppression hypertension and effect of obesity；Owing to rich in ferrum, copper and vitamin C, it can prevent anemia, vitamin C deficiency, vitiligo, prevent the generation of arteriosclerosis and cerebral thrombosis；Its selenium and chromium content are higher, protected liver, pancreas, prevention liver cirrhosis and the effect of diabetes；Se content height makes it also have and prevents and treats Keshan disease, Kaschin-Beck disease and some cardiopathic function；It is held concurrently calcic and vitamin D, and both coordinate, and can effectively prevent and treat rickets；The favourable brain development of higher Zn content, holding oxyopia, promote wound healing；The vitamin E of high-load and selenium coordinate, and make it defying age, memory reinforcing and sensitivity.
Fructus Litchi (formal name used at school Litchi chinensis) is a kind of subtropical fruit tree that SOUTHERN CHINA is produced.Fructus Litchi is the important fruit crops in south China, and annual output is more than 1,000,000 tons.It is again separated branch.Trees are tall and big, and leaves does not falls, and fruit is ripe in five Junes.Poet's Pai Chu-yi once described: " if this fruit leaves trunk, then complexion changed, then fragrant change on the two, then taste change on the three on the one, after four or five days, color is not the most deposited, so name separated branch.”
The seed that source is sapindaceous plant Fructus Litchi Litchi chinensis Sonn. of Semen Litchi extract.Seed is contained within Saponin (1.12%), tannin (3.43%) and alpha-methylene cyclopropylglycine.And isolate the volatile oil of trace, wherein contain 3-Hydroxybutanone, 2,3-butanediol, cluck (king's bar) alkene, cis-Flos Caryophylli alkene, fragrant alkene, oxalene, δ-cubeb, α-curcumene, xanthorrhizol etc..
At present, it is not the most that raw material preparation produces the product obtaining as being prepared as microcapsule by these three material.
Summary of the invention
It is an object of the invention to overcome above-mentioned existing industry prejudice, and a kind of Lac regis apis Semen Litchi Grifola frondosa microcapsule is provided, the component of sensitivity in Lac regis apis is coated, isolating oxygen, light, ultraviolet, prevent oxidation deterioration, reduce the external environment impact on capsule core material.Meanwhile, the core that Lac regis apis is mixed to prepare with Grifola frondosa extracting solution and litchi nucleus extract fluid, give full play to its health-care effect.
For solving above-mentioned technical problem, a kind of Lac regis apis Semen Litchi Grifola frondosa microcapsule that the present invention provides, this microcapsule is made up of outer layer glue wall and internal layer core, described internal layer core is calculated by weight as the Lac regis apis of 40～80 parts, the Grifola frondosa extracting solution of 20～40 parts and the litchi nucleus extract fluid of 5～20 parts, and described outer layer glue wall is calculated by weight as the arabic gum of 100～125 parts, the maltodextrin of 100～125 parts, the gelatin of 10～30 parts and the sucrose of 20～35 parts.
Further, described internal layer core is calculated by weight as the Lac regis apis of 60～80 parts, the Grifola frondosa extracting solution of 20～30 parts and the litchi nucleus extract fluid of 10～20 parts.
Yet further, described internal layer core is calculated by weight as the Lac regis apis of 80 parts, the Grifola frondosa extracting solution of 20 parts and 15 parts of litchi nucleus extract fluids, and described outer layer glue wall is calculated by weight as the arabic gum of 125 parts, the maltodextrin of 125 parts, the gelatin of 20 parts and the sucrose of 30 parts.
Present invention also offers the preparation method of a kind of Lac regis apis Semen Litchi Grifola frondosa microcapsule, comprise the following steps:
1) based on above-mentioned parts by weight, weigh Lac regis apis, Grifola frondosa extracting solution and litchi nucleus extract fluid, mix homogeneously, obtain internal layer core；
2) based on above-mentioned parts by weight, weigh arabic gum, maltodextrin, gelatin and sucrose, obtain outer wall material；
3) being mixed homogeneously with outer wall material by internal layer core, after emulsifying, by pelletize, wall material is solidified, obtaining particle diameter is 1～20 μm Lac regis apis Semen Litchi Grifola frondosa microcapsules.
The beneficial effects of the present invention is:
1, the polysaccharide that the microcapsule of the present invention contains has the positive role of minimizing blood glucose (sugared).The unsaturated fatty acid being included in Effects of Extracts of Grifola frondosa on Active such as linolein, has the effect of reduction blood glucose, cholesterol and arteriosclerosis equally.
2, the microcapsule of the present invention is prepared from by Lac regis apis, Grifola frondosa extracting solution and litchi nucleus extract fluid, this microcapsule also has a lot of polysaccharide, polysaccharide can activated immune response such as macrophage, natural killer cell, T-lymphocyte, and lymphokine and interleukin.These character make it can be used for prophylaxis of cancer.Research shows that it can reduce chemotherapeutic side effect.
3, microcapsule contains Saponin and effectively reduces blood glucose, and its mechanism of action is to improve body and the surrounding tissue utilization rate to glucose.
4, after micro encapsulation, material inside and outside capsule can be isolated by cyst wall, therefore can stop generation chemical reaction between active substance.
5, the maximum feature of microcapsule be can control release within be wrapped material so that it is out or the most gradually discharge in a certain abrupt release.Abrupt release be by extruding, rub, melting, the effect such as dissolving make shell disintegrate；It is then that outside housing, gradually infiltration or shell gradually dissolve, degrade and make Release of core material out by core by ashamed release.After Lac regis apis, Grifola frondosa extracting solution and litchi nucleus extract fluid are made microcapsule, not only convenient oral, it is often more important that it can be made slowly to discharge, make effect lasting, thus can reduce and take number of times and dose, reduce physiological side effects, improve effect value that microcapsule is immediately used by the body.
Detailed description of the invention
In order to preferably explain the present invention, it is further elucidated with the main contents of the present invention below in conjunction with specific embodiment, but present disclosure is not limited solely to following example.
Embodiment 1
A kind of Lac regis apis Semen Litchi Grifola frondosa microcapsule, this microcapsule is made up of outer layer glue wall and internal layer core, internal layer core is calculated by weight as the Lac regis apis of 80 parts, the Grifola frondosa extracting solution of 20 parts and the litchi nucleus extract fluid of 20 parts, and outer layer glue wall is calculated by weight as the arabic gum of 125 parts, the maltodextrin of 125 parts, the gelatin of 30 parts and the sucrose of 20 parts.
The preparation method of Lac regis apis Semen Litchi Grifola frondosa microcapsule, comprises the following steps:
1) based on above-mentioned parts by weight, weigh Lac regis apis, Grifola frondosa extracting solution and litchi nucleus extract fluid, mix homogeneously, obtain internal layer core；
2) based on above-mentioned parts by weight, weigh arabic gum, maltodextrin, gelatin and sucrose, obtain outer wall material；
3) being mixed homogeneously with outer wall material by internal layer core, after emulsifying, by spray drying method pelletize, wall material is solidified, obtaining particle diameter is 1～20 μm Lac regis apis Semen Litchi Grifola frondosa microcapsules.
Embodiment 2
A kind of Lac regis apis Semen Litchi Grifola frondosa microcapsule, this microcapsule is made up of outer layer glue wall and internal layer core, internal layer core is calculated by weight as the Lac regis apis of 40 parts, the Grifola frondosa extracting solution of 40 parts and the litchi nucleus extract fluid of 20 parts, and outer layer glue wall is calculated by weight as the arabic gum of 100 parts, the maltodextrin of 100 parts, the gelatin of 30 parts and the sucrose of 35 parts.
Its preparation method is same as in Example 1.
Embodiment 3
A kind of Lac regis apis Semen Litchi Grifola frondosa microcapsule, this microcapsule is made up of outer layer glue wall and internal layer core, internal layer core is calculated by weight as the Lac regis apis of 60 parts, the Grifola frondosa extracting solution of 30 parts and the litchi nucleus extract fluid of 20 parts, and outer layer glue wall is calculated by weight as the arabic gum of 125 parts, the maltodextrin of 125 parts, the gelatin of 20 parts and the sucrose of 30 parts.
Its preparation method is same as in Example 1.
Embodiment 3
A kind of Lac regis apis Semen Litchi Grifola frondosa microcapsule, this microcapsule is made up of outer layer glue wall and internal layer core, internal layer core is calculated by weight as the Lac regis apis of 80 parts, the Grifola frondosa extracting solution of 20 parts and the litchi nucleus extract fluid of 15 parts, and outer layer glue wall is calculated by weight as the arabic gum of 125 parts, the maltodextrin of 125 parts, the gelatin of 20 parts and the sucrose of 30 parts.
Its preparation method is same as in Example 1.
Embodiment 4
A kind of Lac regis apis Semen Litchi Grifola frondosa microcapsule, this microcapsule is made up of outer layer glue wall and internal layer core, internal layer core is calculated by weight as the Lac regis apis of 40 parts, the Grifola frondosa extracting solution of 40 parts and the litchi nucleus extract fluid of 10 parts, and outer layer glue wall is calculated by weight as the arabic gum of 125 parts, the maltodextrin of 125 parts, the gelatin of 20 parts and the sucrose of 30 parts.
Its preparation method is same as in Example 1.
Embodiment 5
A kind of Lac regis apis Semen Litchi Grifola frondosa microcapsule, this microcapsule is made up of outer layer glue wall and internal layer core, internal layer core is calculated by weight as the Lac regis apis of 80 parts, the Grifola frondosa extracting solution of 20 parts and the litchi nucleus extract fluid of 5 parts, and outer layer glue wall is calculated by weight as the arabic gum of 125 parts, the maltodextrin of 125 parts, the gelatin of 20 parts and the sucrose of 30 parts.
Its preparation method is same as in Example 1.
Below by contrast experiment Lac regis apis Semen Litchi Grifola frondosa microcapsule that embodiment 3 the prepares effectiveness comparison in terms of regulation hyperlipidemia, cholesterol, hyperglycemia is described:
Hyperlipidemia, cholesterol, hyperglycemia patient is chosen by four age brackets, wherein, 30～within 40 years old, to choose 300 examples, 40～50 years old and choose 300 examples, 50～60 years old and choose 300 people, 60～70 years old to choose the M-F of 300 four age brackets of people be 11, female 43 people, according to exceeding country blood fat, cholesterol, the standard of blood glucose, by four age bracket random assortment three groups, in each group, each age bracket has 100 people, and first group of patient is that 400 people, second group of patient are 400 people and the 3rd group of patient is 400 people.Wherein T-CHOL TCHO normal value: 3.0～5.7mmol/L；Triglyceride TG normal value: 0.5～1.7mmol/L；Blood glucose normal value: on an empty stomach less than 6.2, is less than 7.8 in two hours after the meal.
First group (matched group): drink tradition Lac regis apis, every day is the most each once, and each Lac regis apis Folium Camelliae sinensis 5 grams, early, middle and late three warm water brew to be drunk.It was a cycle with one month, within three months, is a course for the treatment of.
Second group (experimental group): take Lac regis apis Semen Litchi Grifola frondosa microcapsule of the present invention, three times a day, each microcapsule 3, early, middle and late three warm water are taken.The microcapsule wherein prepared with embodiment 3 is taken, and the proportion of composing of amount part is 1:1.It was a cycle with one month, within three months, is a course for the treatment of.
3rd group (blank group): drink boiled water, do not drink other beverages and medicine.It was a cycle with one month, within three months, is a course for the treatment of.
Meanwhile, in the trimestral course for the treatment of, it is ensured that the diet situation of the patient in age-grade stage is consistent.
Standard of comparison is set to, and (1) has effective: refer to that within trimestral time blood fat, cholesterol, blood glucose have the decline of bigger degree, already close to, substantially close to or reached standard value.(2) effective: to refer to that within trimestral time blood fat, cholesterol, blood glucose have the decline of bigger degree, have the development trend close to or up standard value.(3) invalid: to refer to that degree that within trimestral time blood fat, cholesterol, blood glucose decline is less or substantially without decline.
As can be known from the above table: by statistical analysis experimental group of the present invention compared with matched group and blank group, have significant difference with matched group having in effective number.Efficiently individual quantity has significant difference with matched group.Invalid number is that matched group is compared and also had significant difference.Meanwhile, best in 30～40 age bracket effects, it is possible to the recovery capability of the patient of 30～40 age brackets is strong, but knowable to three contrasts, Lac regis apis Semen Litchi Grifola frondosa microcapsule health-care effect is more preferable.Other unspecified part is prior art.Although above-described embodiment is made that detailed description to the present invention; but its a part of embodiment that is only the present invention; rather than whole embodiments, people can also obtain other embodiments according to the present embodiment under without creative premise, and these embodiments broadly fall into scope.
Claims (2)
1. a Lac regis apis Semen Litchi Grifola frondosa microcapsule, this microcapsule is by outer layer glue wall and interior
Layer core composition, described internal layer core be calculated by weight as 80 parts Lac regis apis, 20 parts
Grifola frondosa extracting solution and 15 parts of litchi nucleus extract fluids, described outer layer glue wall is calculated by weight as
The arabic gum of 125 parts, the maltodextrin of 125 parts, the gelatin of 20 parts and the sucrose of 30 parts；
It is characterized in that: the preparation method of described Lac regis apis Semen Litchi Grifola frondosa microcapsule, including following
Step:
1) based on above-mentioned parts by weight, weigh Lac regis apis, Grifola frondosa extracting solution and Semen Litchi extract
Liquid, mix homogeneously, obtain internal layer core；
2) based on above-mentioned parts by weight, arabic gum, maltodextrin, gelatin and sucrose are weighed,
Obtain outer wall material；
3) internal layer core is mixed homogeneously with outer wall material, after emulsifying, make wall by pelletize
Material solidifies, and obtaining particle diameter is 1～20 μm Lac regis apis Semen Litchi Grifola frondosa microcapsules.
2. a preparation method for Lac regis apis Semen Litchi Grifola frondosa microcapsule described in claim 1,
It is characterized in that: comprise the following steps:
1) based on above-mentioned parts by weight, weigh Lac regis apis, Grifola frondosa extracting solution and Semen Litchi extract
Liquid, mix homogeneously, obtain internal layer core；
2) based on above-mentioned parts by weight, arabic gum, maltodextrin, gelatin and sucrose are weighed,
Obtain outer wall material；
3) internal layer core is mixed homogeneously with outer wall material, after emulsifying, make wall by pelletize
Material solidifies, and obtaining particle diameter is 1～20 μm Lac regis apis Semen Litchi Grifola frondosa microcapsules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410232902.8A CN104116071B (en) | 2014-05-29 | 2014-05-29 | Lac regis apis Semen Litchi Grifola frondosa microcapsule and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410232902.8A CN104116071B (en) | 2014-05-29 | 2014-05-29 | Lac regis apis Semen Litchi Grifola frondosa microcapsule and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104116071A CN104116071A (en) | 2014-10-29 |
| CN104116071B true CN104116071B (en) | 2016-08-24 |
Family
ID=51761877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410232902.8A Active CN104116071B (en) | 2014-05-29 | 2014-05-29 | Lac regis apis Semen Litchi Grifola frondosa microcapsule and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104116071B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104940380A (en) * | 2015-06-19 | 2015-09-30 | 深圳市神秘果实业有限公司 | Composition containing miracle fruit powder and application thereof serving as medicine or health care product |
| CN105325983A (en) * | 2015-11-20 | 2016-02-17 | 武汉思维特食品有限公司 | Microcapsule containing royal jelly and sea buckthorn and preparation method of microcapsule |
| CN106551422A (en) * | 2016-11-30 | 2017-04-05 | 湖北中烟工业有限责任公司 | Preparation method and application of the cigarette with Semen Ziziphi Spinosae extractum |
| CN110432492A (en) * | 2019-08-26 | 2019-11-12 | 江南大学 | A kind of hypoglycemic nano-clathrate and preparation method thereof |
-
2014
- 2014-05-29 CN CN201410232902.8A patent/CN104116071B/en active Active
Non-Patent Citations (2)
| Title |
|---|
| 荔枝加工副产物研究进展;刘学铭等;《食品研究与开发》;20120131;第33卷(第1期);第202-203页"3.2荔枝核"、第203页右栏"2）荔枝壳和荔枝核功能成分的稳态化技术" * |
| 蜂产品研究现状与展望;吴粹文;《中国养蜂》;19980919;第49卷(第5期);第8-9页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104116071A (en) | 2014-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2335925C2 (en) | Biologically active preparation and method of its manufacturing | |
| KR101433188B1 (en) | Composition For Relieving Alcohol-induced Hangover Comprising Starch, Amino Acids, Active Complex Vitamin And Oriental Herb Medicine materials AND, The Manufacturing Method Thereof | |
| KR102020586B1 (en) | Healthy foods for elderly comprising animal and plant extracts and process for preparation thereof | |
| Navarra | The encyclopedia of vitamins, minerals, and supplements | |
| CN104116071B (en) | Lac regis apis Semen Litchi Grifola frondosa microcapsule and preparation method thereof | |
| CN106722607A (en) | A kind of preparation method of mulberry jam | |
| CN101223988A (en) | Healthy drink for anti-alcoholic, protecting liver, invigorating the spleen and nourishing stomach and preparing method thereof | |
| CN106615468A (en) | Golden camellia plant beverage for replenishing blood and maintaining beauty | |
| KR20150040392A (en) | undiluted stevia liquid and the berages, and its manufacturing method | |
| CN104783185B (en) | It is a kind of that there is strengthen immunity, health food of function of physical fatigue alleviation and preparation method thereof | |
| CN101828617A (en) | Ginseng and lucid ganoderma instant tea | |
| Kieliszek et al. | Recent advances and opportunities related to the use of bee products in food processing | |
| CN104186852A (en) | Peony flower tea and preparation method thereof | |
| KR20130056780A (en) | Cosmetic composition comprising soapnut | |
| US20180296615A1 (en) | Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient | |
| KR101764306B1 (en) | The method for manufacturing of tea | |
| CN102934719A (en) | Gingko tartary buckwheat tea and preparation technology thereof | |
| CN105410892A (en) | Insect active protein powder | |
| KR20200048459A (en) | Preparation manufacturing of composition for the improving of respiratory disease comprising pear and citron, and composition prepared thereby | |
| JP2001275587A (en) | Method of extracting propolis and food including the same | |
| CN102934718A (en) | Sea buckthorn fruit tartary buckwheat tea and preparation process thereof | |
| CN113841884A (en) | Formula of instant meal replacement powder for improving nutrient metabolism and preparation method thereof | |
| CN105325983A (en) | Microcapsule containing royal jelly and sea buckthorn and preparation method of microcapsule | |
| RU2358562C1 (en) | Vegetable concentrate for "kazan-bionan-3" functional drink | |
| KR20080090101A (en) | Nutraceuticals using marine, plant capsosiphon fulvescens(mesangi) and its process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 430301 Hengdian Street Hengtian Road, Huangpi District, Wuhan City, Hubei Province Patentee after: Wuhan Sinter Food Co., Ltd. Address before: 430301 Hengdian Street Hengtian Road, Huangpi District, Wuhan City, Hubei Province Patentee before: WUHAN SIWEITE FOOD CO., LTD. |
|
| CP01 | Change in the name or title of a patent holder |